Agenda

Session C: Oral Abstracts

Tracks

Wednesday, September 6, 2017

1:00 PM - 2:20 PM

Hudson I, II & III

Speaker

Attendee435

Injection Partner Mixing: Higher Risk Of HCV among Young Adults who Inject Drugs with Younger Injecting Partners

1:00 PM - 1:15 PM

Abstract

Speaker Presentation

Biography

Attendee335

Examining The Association Between Prescription Opioid Injection And HCV Transmission During Transition of a Drug Epidemic in Montreal, Canada

1:15 PM - 1:30 PM

Abstract

Biography

Attendee279

Injecting Risk Behaviours among People who Inject Drugs in an Australian Prison Setting, 2005-2014: The Hits-P Study

1:30 PM - 1:45 PM

Abstract

Speaker Presentation

Biography

Attendee407

Implementation of Ghost for Detection of HCV Transmission Network by Tennessee Department of Health

1:45 PM - 2:00 PM

Abstract

Speaker Presentation

Biography

Attendee233

One-Year Injecting Frequency Trajectories as Predictors of Hepatitis C Acquisition: Findings from an Observational Cohort of People who Inject Drugs in Montréal, Canada

2:00 PM - 2:05 PM

Abstract

Speaker Presentation

Biography

Attendee400

The Cost-Effectiveness of Needle and Syringe Provision in Preventing Transmission of Hepatitis C Virus in People who Inject Drugs

2:05 PM - 2:10 PM

Abstract

Biography

Attendee714

From Client to Co-Worker: Peer Work within a Harm Reduction Hepatitis C Treatment Program in Toronto, Canada

2:10 PM - 2:15 PM

Abstract

Speaker Presentation

Biography

Attendee364

Collaborative HCV Learning Model for Patients and Clinicians in Substance Use Disorder Clinics: 2016-2017 Findings on Knowledge and Perceptions

2:15 PM - 2:20 PM